Hepatic Resection
Conditions
Keywords
Patients undergoing hepatic resection
Brief summary
There is clinical uncertainty and ongoing discussion among liver surgeons regarding the optimal method of parenchymal transection in patients undergoing elective hepatic resection. While the clamp-crushing technique still represents the reference technique for routine liver resections, transection of liver parenchyma using vascular staplers may offer a new and safe technique potentially reducing intraoperative blood loss, operation time as well as peri-operative morbidity. As morbidity of patients undergoing hepatic resection remains high, approaches to lower peri-operative complications are urgently required. Due to the lack of evidence it has to be evaluated, if the technique of stapler hepatectomy decreases intraoperative blood loss as a highly relevant predictor of peri-operative complications, patients' hospital stay and finally health care expenditures. These advantages would favor stapler hepatectomy to be applied in routine liver resections. As RCTs are generally considered to generate the most valid scientific evidence on a treatment's effects, the present trial evaluates potential benefits of stapler hepatectomy in a randomized fashion.
Interventions
The transectional line is marked and the liver capsule is cauterized. The liver parenchyma is then crushed stepwise using a regular Pèan clamp. Vessels and bile ducts are ligated or clipped. Vessels of less than 2mm diameter are coagulated with the irrigated bipolar forceps.
The transectional line is marked and the liver capsule is cauterized. For subsequent transection of the hepatic parenchyma, the liver tissue is fractured with a vascular clamp in a stepwise fashion and subsequently divided with endo GIA vascular staplers.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients scheduled for elective hepatic resection * Stapler hepatectomy and clamp-crushing feasible based on preoperative imaging * Age equal or greater than 18 years * Informed consent
Exclusion criteria
* Participation in concurrent intervention trials * Expected lack of compliance * Impaired mental state or language problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative blood loss | 2.5 hours |
Countries
Germany